Institutional Ownership
Fulcrum Therapeutics Inc
CUSIP 359616109COMFULCQ1 2026
Earnings
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).